Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma

BACKGROUND: Germline genetic testing for familial cancer syndromes is usually performed serially for the most likely genetic causes. In recent years the way genetic testing carried out has changed, as next generation sequencing now allows the simultaneous testing of multiple susceptibility genes at...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Heitzer, Ellen, Lax, Sigurd, Lafer, Ingrid, Müller, Stephanie M, Pristauz, Gunda, Ulz, Peter, Jahn, Stephan, Högenauer, Christoph, Petru, Edgar, Speicher, Michael R, Geigl, Jochen B
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913615/
https://ncbi.nlm.nih.gov/pubmed/24373500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2350-14-129
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi